Status:

TERMINATED

MyPrEP Plus: Development and Pilot Testing of Novel Preexposure Prophylaxis Decision Support Tools for Transgender Women

Lead Sponsor:

Public Health Foundation Enterprises, Inc.

Conditions:

HIV Pre-exposure Prophylaxis

HIV Prevention and Care

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

The primary goal of this randomized controlled trial is to learn if a decision support tool called MyPrEP Plus can help transgender women make decisions about taking pre-exposure prophylaxis (PrEP) fo...

Detailed Description

In this clinical study, 60 transgender women will be randomly assigned to one of two groups, either PrEP support via standard of care through pleaseprepme.org (control condition) or PrEP support with ...

Eligibility Criteria

Inclusion

  • Are age 18 or older
  • Identify as a transgender woman or woman and was assigned male sex at birth
  • Are not currently on PrEP in the last three months and interested in learning more about PrEP
  • Able to successfully send and receive text messages
  • HIV negative by self-report
  • Are able to speak, read and write in English or Spanish
  • Report any of the following in the last 12 months:
  • Having anal or vaginal sex with a person assigned male at birth
  • Exchange of sex for money, goods, or services
  • Received a diagnosis of a sexually transmitted infection
  • Sharing injection equipment
  • Are able and willing to provide written informed consent and participate for the duration of the study

Exclusion

  • In a mutually monogamous sexual relationship with an HIV-negative partner for the past 12 months
  • Of any medical, psychiatric, or social condition that in the opinion of the investigator would preclude participation or their ability to remain in the trial
  • Study site staff member

Key Trial Info

Start Date :

March 18 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 21 2025

Estimated Enrollment :

2 Patients enrolled

Trial Details

Trial ID

NCT07146139

Start Date

March 18 2023

End Date

March 21 2025

Last Update

August 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Bridge HIV, San Francisco Department of Public Health

San Francisco, California, United States, 94102